Volume 3, Issue 1: Shifting Paradigm of Type 2 Diabetes: From Neutrality to Benefit on Cardiovascular Outcomes

e-Diabetes Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with diabetes. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.

(Volume 3, Issue 1)

Target Audience

Nurses and health care professionals involved in the care of patients with diabetes.

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to:

  • Identify antihyperglycemic medications that have been shown to reduce composite
    cardiovascular disease risk (death from cardiovascular causes, nonfatal myocardial
    infarction, and nonfatal stroke) in patients with type 2 diabetes at high risk for CVD.
  • Discuss the association between DPP-4 inhibitors and congestive heart failure.
  • Describe expected clinical outcomes when using metformin in patients with previous
    historical contraindications or precautions (congestive heart failure, chronic kidney
    disease, and chronic liver disease).
Additional information
Contact email: 
Course summary
Available credit: 
  • 1.00 ANCC
  • 1.00 Attendance
Course opens: 
11/09/2017
Course expires: 
11/08/2019
Cost:
$0.00
Nestoras Mathioudakis, MD
Assistant Professor of Medicine
Division of Endocrinology, Diabetes, & Metabolism
Associate Director, Inpatient Diabetes Management Service Program
Johns Hopkins University School of Medicine
Baltimore, Maryland
 

Available Credit

  • 1.00 ANCC
  • 1.00 Attendance

Accreditation Period

Course opens: 
11/09/2017
Course expires: 
11/08/2019

Price

Cost:
$0.00
Please login or register to take this course.